blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2563932

EP2563932 - DETECTION OF IMMUNE CELLS, IN PARTICULAR T CELLS THROUGH DNA-METHYLATION ANALYSIS OF THE GENES CCR6 [Right-click to bookmark this link]
Former [2013/10]DETECTION OF IMMUNE CELLS, IN PARTICULAR T CELLS THROUGH DNA-METHYLATION ANALYSIS OF THE GENES CCR6 AND BLR1
[2017/48]
StatusNo opposition filed within time limit
Status updated on  05.10.2018
Database last updated on 30.07.2024
FormerThe patent has been granted
Status updated on  27.10.2017
FormerGrant of patent is intended
Status updated on  27.06.2017
FormerExamination is in progress
Status updated on  20.01.2017
Most recent event   Tooltip10.07.2020Lapse of the patent in a contracting state
New state(s): AL, IS		published on 12.08.2020  [2020/33]
Applicant(s)For all designated states
Epiontis GmbH
Rudower Chaussee 29
12489 Berlin / DE
[2013/10]
Inventor(s)01 / OLEK, Sven
Boothstrasse 16
12207 Berlin / DE
 [2013/10]
Representative(s)Krauss, Jan
Boehmert & Boehmert
Anwaltspartnerschaft mbB
Pettenkoferstrasse 22
80336 München / DE
[2017/48]
Former [2013/10]Krauss, Jan
Boehmert & Boehmert
Pettenkoferstrasse 20-22
80336 München / DE
Application number, filing date11716573.829.04.2011
[2017/48]
WO2011EP56871
Priority number, dateUS20100329229P29.04.2010         Original published format: US 329229 P
[2013/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011135088
Date:03.11.2011
Language:EN
[2011/44]
Type: A1 Application with search report 
No.:EP2563932
Date:06.03.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 03.11.2011 takes the place of the publication of the European patent application.
[2013/10]
Type: B1 Patent specification 
No.:EP2563932
Date:29.11.2017
Language:EN
[2017/48]
Search report(s)International search report - published on:EP03.11.2011
ClassificationIPC:C12Q1/68
[2013/10]
CPC:
C12Q1/6883 (EP,US); C12Q1/686 (US); C12Q1/6876 (US);
C12Q1/6869 (US); C12Q2523/125 (US); C12Q2600/154 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/10]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:NACHWEIS VON IMMUNZELLEN MITTELS DNA-METHYLIERUNGSANALYSE DES GENS CCR6[2017/48]
English:DETECTION OF IMMUNE CELLS, IN PARTICULAR T CELLS THROUGH DNA-METHYLATION ANALYSIS OF THE GENES CCR6[2017/48]
French:DÉTECTION DES CELLULES IMMUNITAIRES, EN PARTICULIER VIA L'ANALYSE DE MÉTHYLATION DE L'ADN DU GÈNES CCR6[2017/48]
Former [2013/10]NACHWEIS VON IMMUNZELLEN, IM BESONDEREN T-ZELLEN, DURCH DNA-METHYLIERUNGSANALYSE DER GENE CCR6 UND BLR1
Former [2013/10]DETECTION OF IMMUNE CELLS, IN PARTICULAR T CELLS THROUGH DNA-METHYLATION ANALYSIS OF THE GENES CCR6 AND BLR1
Former [2013/10]DÉTECTION DE CELLULES IMMUNITAIRES, EN PARTICULIER DE LYMPHOCYTES T, PAR L'ANALYSE DE LA MÉTHYLATION DE L'ADN DES GÈNES CCR6 ET BLR1
Entry into regional phase29.11.2012National basic fee paid 
29.11.2012Designation fee(s) paid 
29.11.2012Examination fee paid 
Examination procedure29.11.2012Examination requested  [2013/10]
18.07.2013Amendment by applicant (claims and/or description)
19.09.2016Despatch of a communication from the examining division (Time limit: M04)
17.01.2017Reply to a communication from the examining division
28.06.2017Communication of intention to grant the patent
20.10.2017Fee for grant paid
20.10.2017Fee for publishing/printing paid
20.10.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  19.09.2016
Opposition(s)30.08.2018No opposition filed within time limit [2018/45]
Fees paidRenewal fee
12.04.2013Renewal fee patent year 03
26.02.2014Renewal fee patent year 04
10.04.2015Renewal fee patent year 05
29.03.2016Renewal fee patent year 06
10.04.2017Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU29.04.2011
AL29.11.2017
CY29.11.2017
EE29.11.2017
FI29.11.2017
HR29.11.2017
LT29.11.2017
LV29.11.2017
MC29.11.2017
MK29.11.2017
PT29.11.2017
RO29.11.2017
RS29.11.2017
SI29.11.2017
SK29.11.2017
SM29.11.2017
TR29.11.2017
BG28.02.2018
NO28.02.2018
GR01.03.2018
IS29.03.2018
MT29.04.2018
[2020/33]
Former [2020/31]HU29.04.2011
CY29.11.2017
EE29.11.2017
FI29.11.2017
HR29.11.2017
LT29.11.2017
LV29.11.2017
MC29.11.2017
MK29.11.2017
PT29.11.2017
RO29.11.2017
RS29.11.2017
SI29.11.2017
SK29.11.2017
SM29.11.2017
TR29.11.2017
BG28.02.2018
NO28.02.2018
GR01.03.2018
MT29.04.2018
Former [2020/27]HU29.04.2011
CY29.11.2017
EE29.11.2017
FI29.11.2017
HR29.11.2017
LT29.11.2017
LV29.11.2017
MC29.11.2017
PT29.11.2017
RO29.11.2017
RS29.11.2017
SI29.11.2017
SK29.11.2017
SM29.11.2017
TR29.11.2017
BG28.02.2018
NO28.02.2018
GR01.03.2018
MT29.04.2018
Former [2020/16]CY29.11.2017
EE29.11.2017
FI29.11.2017
HR29.11.2017
LT29.11.2017
LV29.11.2017
MC29.11.2017
RO29.11.2017
RS29.11.2017
SI29.11.2017
SK29.11.2017
SM29.11.2017
TR29.11.2017
BG28.02.2018
NO28.02.2018
GR01.03.2018
MT29.04.2018
Former [2020/08]CY29.11.2017
EE29.11.2017
FI29.11.2017
HR29.11.2017
LT29.11.2017
LV29.11.2017
MC29.11.2017
RO29.11.2017
RS29.11.2017
SI29.11.2017
SK29.11.2017
SM29.11.2017
BG28.02.2018
NO28.02.2018
GR01.03.2018
MT29.04.2018
Former [2018/52]CY29.11.2017
EE29.11.2017
FI29.11.2017
HR29.11.2017
LT29.11.2017
LV29.11.2017
MC29.11.2017
RO29.11.2017
RS29.11.2017
SI29.11.2017
SK29.11.2017
SM29.11.2017
BG28.02.2018
NO28.02.2018
GR01.03.2018
Former [2018/40]CY29.11.2017
EE29.11.2017
FI29.11.2017
HR29.11.2017
LT29.11.2017
LV29.11.2017
RO29.11.2017
RS29.11.2017
SK29.11.2017
SM29.11.2017
BG28.02.2018
NO28.02.2018
GR01.03.2018
Former [2018/37]CY29.11.2017
EE29.11.2017
FI29.11.2017
HR29.11.2017
LT29.11.2017
LV29.11.2017
RS29.11.2017
SK29.11.2017
SM29.11.2017
BG28.02.2018
NO28.02.2018
GR01.03.2018
Former [2018/25]FI29.11.2017
HR29.11.2017
LT29.11.2017
LV29.11.2017
RS29.11.2017
BG28.02.2018
NO28.02.2018
GR01.03.2018
Former [2018/22]FI29.11.2017
LT29.11.2017
NO28.02.2018
Cited inInternational search[XYI]  - BARON UDO ET AL, "DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells.", EUROPEAN JOURNAL OF IMMUNOLOGY, (200709), vol. 37, no. 9, ISSN 0014-2980, pages 2378 - 2389, XP002639439 [X] 1-7,12-17 * the whole document * [Y] 18 [I] 8-11,19-22
 [XI]  - Baron U. et. al., "Suporting information: DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3+ conventional T cells", European Journal of Immunology, URL: http://www.wiley-vch.de/contents/jc_2040/2007/37594_s.pdf, (200709), XP002644060 [X] 1-7,12-17 * the whole document * [I] 8-11,19-22
 [IAY]  - KOENEN HANS J P M ET AL, "Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells.", BLOOD, (20080915), vol. 112, no. 6, ISSN 1528-0020, pages 2340 - 2352, XP002639440 [I] 18 * the whole document * [A] 1-17,19-23 [Y] 18

DOI:   http://dx.doi.org/101.1182/BLOOD-2008-01-133967
 [IA]  - MIZUKAMI TAKUO ET AL, "Five azacytidine, a DNA methyltransferase inhibitor, specifically inhibits testicular cord formation and Sertoli cell differentiation in vitro.", MOLECULAR REPRODUCTION AND DEVELOPMENT, (200806), vol. 75, no. 6, ISSN 1098-2795, pages 1002 - 1010, XP002639441 [I] 19,20 * the whole document * [A] 1-18,21-23

DOI:   http://dx.doi.org/10.1002/MRD.20850
 [A]  - KLEINEWIETFELD MARKUS ET AL, "CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset.", BLOOD, (20050401), vol. 105, no. 7, ISSN 0006-4971, pages 2877 - 2886, XP002639442 [A] 1-23 * the whole document *

DOI:   http://dx.doi.org/10.1182/BLOOD-2004-07-2505
 [A]  - HENNEKEN MAREN ET AL, "Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.", ARTHRITIS RESEARCH & THERAPY, (2005), vol. 7, no. 5, ISSN 1478-6362, pages R1001 - R1013, XP002639443 [A] 1-23 * the whole document *

DOI:   http://dx.doi.org/10.1186/AR1776
 [A]  - WIECZOREK GEORG ET AL, "Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue.", CANCER RESEARCH, (20090115), vol. 69, no. 2, ISSN 1538-7445, pages 599 - 608, XP002639444 [A] 1-23 * the whole document *
 [A]  - HOFFMANN PETRA ET AL, "Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation.", EUROPEAN JOURNAL OF IMMUNOLOGY, (200904), vol. 39, no. 4, ISSN 1521-4141, pages 1088 - 1097, XP002639445 [A] 1-23 * the whole document *
 [A]  - POLANSKY JULIA K ET AL, "DNA methylation controls Foxp3 gene expression.", EUROPEAN JOURNAL OF IMMUNOLOGY, (200806), vol. 38, no. 6, ISSN 0014-2980, pages 1654 - 1663, XP002639446 [A] 1-23 * the whole document *

DOI:   http://dx.doi.org/10.1002/EJI.200838105
by applicantWO9928468
 US6110695
 WO03014153
    - KAISER E, FORSTER R, WOLF I, EBENSPERGER C, KUEHL WM, LIPP M., "The G protein-coupled receptor BLR1 is involved in murine B cell differentiation and is also expressed in neuronal tissues", EUR J IMMUNOL., (199310), vol. 23, no. 10, doi:doi:10.1002/eji.1830231023, pages 2532 - 9, XP002097372

DOI:   http://dx.doi.org/10.1002/eji.1830231023
    - FORSTER R, WOLF I, KAISER E, LIPP M., "Selective expression of the murine homologue of the G-protein-coupled receptor BLR1 in B cell differentiation, B cell neoplasia and defined areas of the cerebellum", CELL MOL BIOL, (199405), vol. 40, no. 3, pages 381 - 7, XP008137125
    - BERAHOVICH RD, LAI NL, WEI Z, LANIER LL, SCHALL TJ., "Evidence for NK cell subsets based on chemokine receptor expression", J IMMUNOL., (2006), vol. 177, pages 7833 - 7840
    - DIEU MC, VANBERVLIET B, VICARI A ET AL., "Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites", J EXP MED., (1998), vol. 188, pages 373 - 386
    - HIROTA K, YOSHITOMI H, HASHIMOTO M ET AL., "Preferential recruitment of CCR6- expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model", J EXP MED., (2007), vol. 204, pages 2803 - 2812
    - HIROTA K, YOSHITOMI H, HASHIMOTO M ET AL., "Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model", J EXP MED., (2007), vol. 204, pages 2803 - 2812
    - RUTH JH, SHAHRARA S, PARK CC ET AL., "Role of macrophage inflammatory protein-3alpha and its ligand CCR6 in rheumatoid arthritis", LAB INVEST., (2003), vol. 83, doi:doi:10.1097/01.LAB.0000062854.30195.52, pages 579 - 588, XP055178014

DOI:   http://dx.doi.org/10.1097/01.LAB.0000062854.30195.52
    - HOMEY B, DIEU-NOSJEAN MC, WIESENBORN A ET AL., "Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis", J IMMUNOL., (2000), vol. 164, pages 6621 - 6632, XP002241101
    - HEDRICK MN, LONSDORF AS, SHIRAKAWA AK ET AL., "CCR6 is required for IL-23-induced psoriasis-like inflammation in mice", J CLIN INVEST., (2009), vol. 119, doi:doi:10.1172/JCI37378, pages 2317 - 2329, XP055034265

DOI:   http://dx.doi.org/10.1172/JCI37378
    - KASER A, LUDWICZEK 0, HOLZMANN S ET AL., "Increased expression of CCL20 in human inflammatory bowel disease", J CLIN IMMUNOL., (2004), vol. 24, pages 74 - 85
    - REBOLDI A, COISNE C, BAUMJOHANN D ET AL., "C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE", NAT IMMUNOL., (2009), vol. 10, pages 514 - 523
    - VARONA R, CADENAS V, FLORES J, MARTINEZ AC, MARQUEZ G., "CCR6 has a non-redundant role in the development of inflammatory bowel disease", EUR J IMMUNOL., (2003), vol. 33, doi:doi:10.1002/eji.200324347, pages 2937 - 2946, XP008048156

DOI:   http://dx.doi.org/10.1002/eji.200324347
    - MATSUI T, AKAHOSHI T, NAMAI R ET AL., "Selective recruitment of CCR6-expressing cells by increased production of MIP-3 alpha in rheumatoid arthritis", CLIN EXP IMMUNOL., (2001), vol. 125, doi:doi:10.1046/j.1365-2249.2001.01542.x, pages 155 - 161, XP002965711

DOI:   http://dx.doi.org/10.1046/j.1365-2249.2001.01542.x
    - BUTCHER EC, PICKER LJ., "Lymphocyte homing and homeostasis", SCIENCE, (1996), vol. 272, pages 60 - 66
    - ACOSTA-RODRIGUEZ EV, RIVINO L, GEGINAT J ET AL., "Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells", NAT IMMUNOL., (2007), vol. 8, doi:doi:10.1038/ni1467, pages 639 - 646, XP002496162

DOI:   http://dx.doi.org/10.1038/ni1467
    - ANSEL KM, LEE DU, RAO A, "An epigenetic view of helper T cell differentiation", NAT IMMUNOL., (2003), vol. 4, doi:doi:10.1038/ni0703-616, pages 616 - 623, XP055004912

DOI:   http://dx.doi.org/10.1038/ni0703-616
    - ZHU J, PAUL WE., "CD4 T cells: fates, functions, and faults", BLOOD, (2008), vol. 112, pages 1557 - 1569
    - WILSON CB, ROWELL E, SEKIMATA M, "Epigenetic control of T-helper-cell differentiation", NAT REV IMMUNOL., (2009), vol. 9, doi:doi:10.1038/nri2487, pages 91 - 105, XP055004880

DOI:   http://dx.doi.org/10.1038/nri2487
    - FLOESS S, FREYER J, SIEWERT C ET AL., "Epigenetic control of the foxp3 locus in regulatory T cells", PLOS BIOL., (2007), vol. 5, page E38
    - HUEHN J, POLANSKY JK, HAMANN A., "Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?", NAT REV IMMUNOL., (2009), vol. 9, doi:doi:10.1038/nri2474, pages 83 - 89, XP055325587
    - BARON U, FLOESS S, WIECZOREK G ET AL., "DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3+ conventional T cells", EUR J IMMUNOL., (2007), vol. 37, pages 2378 - 2389
    - SCOTET E, SCHROEDER S, LANZAVECCHIA A., "Molecular regulation of CC-chemokine receptor 3 expression in human T helper 2 cells", BLOOD, (2001), vol. 98, pages 2568 - 2570
    - SYRBE U, JENNRICH S, SCHOTTELIUS A, RICHTER A, RADBRUCH A, HAMANN A., "Differential regulation of P-selectin ligand expression in naive versus memory T cells: evidence for epigenetic regulation of involved glycosyltransferase genes", BLOOD, (2004), vol. 104, pages 3243 - 3248
    - SATO N, MATSUBAYASHI H, FUKUSHIMA N, GOGGINS M., "The chemokine receptor CXCR4 is regulated by DNA methylation in pancreatic cancer", CANCER BIOL THER., (2005), vol. 4, pages 70 - 76
    - MORI T, KIM J, YAMANO T ET AL., "Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells", CANCER RES., (2005), vol. 65, pages 1800 - 1807
    - BABA, M., IMAI, T., NISHIMURA, M., KAKIZAKI, M., TAKAGI, S., HIESHIMA, K., NOMIYAMA, H., YOSHIE, O., "Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC", J. BIOL. CHEM., (1997), vol. 272, no. 23, doi:doi:10.1074/jbc.272.23.14893, pages 14893 - 14898, XP002055488

DOI:   http://dx.doi.org/10.1074/jbc.272.23.14893
    - RUBIE, C., OLIVEIRA, V., KEMPF, K., WAGNER, M., TILTON, B., RAU, B., KRUSE, B., KONIG, J., SCHILLING, M., INVOLVEMENT OF CHEMOKINE RECEPTOR CCR6 IN COLORECTAL CANCER METASTASIS TUMOUR BIOL., (2006), vol. 27, no. 3, pages 166 - 174
    - ANTEQUERA, BIRD, PROC NATL ACAD SCI U S A., (1993), vol. 90, pages 11995 - 9
    - JONES, LAIRD, NATURE GENETICS, (1999), vol. 21, pages 163 - 167
    - ESTELLER, ONCOGENE, (2002), vol. 21, pages 5427 - 5440
    - LAIRD, NATURE REVIEWS/CANCER, (2003), vol. 3, pages 253 - 266
    - J CELLULAR CHEM, (2003), vol. 88, pages 899 - 910
    - BIRD, GENES AND DEV, (2002), vol. 16, pages 6 - 21
    - LI, NATURE REVIEWS/GENETICS, (2002), vol. 3, pages 662 - 673
    - ERLICH, J CELLULAR CHEM, (2003), vol. 88, pages 899 - 910
    - ANSEL ET AL., NATURE IMMUNOL, (2003), vol. 4, pages 616 - 623
    - ATTWOOD ET AL., CMLS, (2002), vol. 59, pages 241 - 257
    - LEE ET AL., IMMUNITY, (2002), vol. 16, pages 649 - 660
    - BRUNIQUEL, SCHWARTZ, NAT IMMUNOL., (2003), vol. 4, pages 235 - 40
    - KUCHARZIK T, HUDSON JT, 3RD, WAIKEL RL, MARTIN WD, WILLIAMS IR., "CCR6 expression distinguishes mouse myeloid and lymphoid dendritic cell subsets: demonstration using a CCR6 EGFP knock-in mouse", EUR J IMMUNOL., (2002), vol. 32, pages 104 - 112
    - MANEL N, UNUTMAZ D, LITTMAN DR., "The differentiation of human T(H)-17 cells requires transforming growth factor- beta and induction of the nuclear receptor ROR-gamma-t", NAT IMMUNOL., (2008), vol. 9, pages 641 - 649
    - BHARAT A, FIELDS RC, MOHANAKUMAR T., REGULATORY T CELL-MEDIATED TRANSPLANTATION TOLERANCE. IMMUNOL RES. 2006, vol. 33, no. 3, pages 195 - 212
    - KHAZAIE K, VON BOEHMER H., "The impact of CD4(+)CD25(+) Treg on tumor specific CD8(+) T cell cytotoxicity and cancer", SEMIN CANCER BIOL., (20060126), vol. 16, no. 2, doi:doi:10.1016/j.semcancer.2005.11.006, pages 124 - 136, XP024908074

DOI:   http://dx.doi.org/10.1016/j.semcancer.2005.11.006
    - LIAO F, RABIN RL, SMITH CS, SHARMA G, NUTMAN TB, FARBER JM., "CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha", J IMMUNOL., (1999), vol. 162, pages 186 - 194
    - SATO K, KAWASAKI H, NAGAYAMA H ET AL., "Chemokine receptor expressions and responsiveness of cord blood T cells", J IMMUNOL., (2001), vol. 166, pages 1659 - 1666
    - POLANSKY JK, KRETSCHMER K, FREYER J ET AL., "DNA methylation controls Foxp3 gene expression", EUR J IMMUNOL., (2008), vol. 38, doi:doi:10.1002/EJI.200838105, pages 1654 - 1663, XP002639446

DOI:   http://dx.doi.org/10.1002/EJI.200838105
    - OLEK A, OSWALD J, WALTER J., "A modified and improved method for bisulphite based cytosine methylation analysis", NUCLEIC ACIDS RES., (1996), vol. 24, doi:doi:10.1093/nar/24.24.5064, pages 5064 - 5066, XP002106408

DOI:   http://dx.doi.org/10.1093/nar/24.24.5064
    - LEWIN J, SCHMITT AO, ADORJAN P, HILDMANN T, PIEPENBROCK C., "Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates", BIOINFORMATICS, (2004), vol. 20, doi:doi:10.1093/bioinformatics/bth346, pages 3005 - 3012, XP002467526

DOI:   http://dx.doi.org/10.1093/bioinformatics/bth346
    - KLEINEWIETFELD M, PUENTES F, BORSELLINO G, BATTISTINI L, ROTZSCHKE 0, FALK K., "CCR6 expression defines regulatory effector/memory-like cells within the CD25+CD4+ T-cell subset", BLOOD, (2005), vol. 105, doi:doi:10.1182/BLOOD-2004-07-2505, pages 2877 - 2886, XP002639442

DOI:   http://dx.doi.org/10.1182/BLOOD-2004-07-2505
    - GEGINAT J, SALLUSTO F, LANZAVECCHIA A., "Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells", J EXP MED., (2001), vol. 194, pages 1711 - 1719
    - SALLUSTO F, KREMMER E, PALERMO B ET AL., "Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells", EUR J IMMUNOL., (1999), vol. 29, doi:doi:10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.3.CO;2-M, pages 2037 - 2045, XP001008570

DOI:   http://dx.doi.org/10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.3.CO;2-M
    - MAIER H, COLBERT J, FITZSIMMONS D, CLARK DR, HAGMAN J., "Activation of the early B-cell-specific mb-1 (Ig-alpha) gene by Pax-5 is dependent on an unmethylated Ets binding site", MOL CELL BIOL., (2003), vol. 23, pages 1946 - 1960
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.